A UAB researcher focusing on the epigenetics of drug abuse wins a significant funding award from the National Institutes of Health.
The drug inhibits the activity of a kinase enzyme called LRRK2, and it showed no pathology in rat lungs, kidneys or livers.
The LIBERATE Study will further investigate the Eclipse System, the first vaginal insert designed to provide bowel control.
Hundreds of students will present academic pursuits in cutting-edge research topics.
UAB offers two national clinical trials with customized treatment for lung cancer patients.
Macrophage cells require agility to scavenge and digest dead cells and prevent an immune response to self. In lupus, the macrophages lose that agility.
A series of fascinating studies at Harvard University showed that many people respond positively to placebo pills — even when they are told that the pills don't have any active ingredients. Now researchers at UAB have partnered with a Harvard scientist to test these "open-label" placebos for the first time in cancer survivors.
Deadlines for abstracts are set for early fall and are open to graduate students, postdoctoral fellows, clinical fellows and residents.
Join a UAB team or create a team for the annual walk, which helps raise funds for research efforts.
Boni Elewski, M.D., and Wendy Cantrell, DNP, pursue research and therapies that bring new drugs to market and change patients’ lives.